Kaplan-Meier estimates of event-free survival within the first 180 days after allogeneic stem cell transplantation in both study groups.

Events were defined as the occurrence of CMV disease or death from any cause. There was no significant difference between patients treated with foscarnet (dotted line; n = 110) and patients treated with ganciclovir (straight line; n = 103) (P = .6).